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The idea that many drugs act by interaction with
specific sites, or "receptors1 in living tissues was
first proposed by Langley (1878, 1905)» but it is
generally with Paul Ehrlich (I8y0) that this concept is
associated, ihrlich's work in immunochemistry led him
to the idea that drugs act by combining with certain
complementary areas of larger molecules, and that
biolo^iuvi responses were the result of this combination.
These areas he called "receptors", - "that combining
group of the protoplasmic molecule to which a foreign
group, when introduced, attaches itself".
The concept of receptors has flourished since the
days of iihrlich, and it was Clark (192b) and Gadduxn (1937)
who made the first attempts to investigate the situation
liuantitatively. Clark demonstrated that many dx*ugs act
at specific sites on cells by his calculations of the
fraction of the surface area of frog ventricle cells
which was covered by the molecules of a drug administered
in sufficient concentration to produce a recognisable
response. This he found to be of the order of 1/1000
for acetylcholine. Similar calculations with other
-2-
active drugs show that they cannot cover more than a
tiny fraction of the cells in effective doses, while some
drugs produce effects only when the dose given is
sufficient to form a monomolecular layer over the whole
cell surface. This indicates that drugs may act in one
of two ways: either by involving a small fraction of
the cell surface, or by covering a large area. The drugs
which require to cover the whole cell to produce a
response most likely act by some physico-chemical
mechanism, while the action of the other type of drug
seems likely to involve receptors or active sites on the
cell surface.
Clark used a modified version of the Langmuir
adsorption isotherm to account for the interaction of
drug molecules with recpptors.
K li\_/ - -2-
1-Y
where K is the affinity constant and is given by ki/ka
f
kj being the rate of association and ka the rate of
dissociations Y is the fraction of receptors occupied
by the drug in a concentration / A_/,
3'
When 50% of the receptors are occupied, then
K = \/ftJ (2)
Clark, however, while testing this equation experimentally,
made the assumption that the biological response was
proportional to the fraction of receptors occupied,
although he did mention that this assumption might not
be valid.
Gaddura (1937) introduced theoretical equations for
the situation in which both an active stimulating drug,
or agonist, and an antagonist, (i.e. a drug which
combines with receptors but elicits no biological
response) were competing for the same receptors:
^ (i ♦ Z»-Ab> (3)
where /_ Aand / B__/are the concentrations of agonist
and antagonist respectively, and are the affinity
constants of agoniBt and antagonist, and Y is the
fraction of receptors occupied by the agonist. If no
antagonist is present, (/ B_/ =0), then this equation
reduces to / A_/K.a = as before. If the responseA
1-Y
to a concentration / of agonist in the presence
-u-
of a concentration / B_/ of antagonist is the same as
the response to a concentration / a_/ of agonist acting
alone, then
43-4 = i +/"B_/K„ (4)
/aV B
This is the basis of experiments designed to measure the
affinity constants of antagonists. If the dose ratio,
/ l*J) is 2, then
*B - 2\7 («
it is also the basis of the pAx scale of measurement of
drug antagonism which was introduced by Bchild (I9h7)»
pAx oeing "the negative logarithm to the base 10 of the
molar concentration of an antagonistic drug which will
reduce the effect of a multiple dose (x) of an active
drug to that of a single dose".
These basic ideas of Clark and Gaddum were more
recently revised by Ariens (195H) and by Stephenson (1956)
Previously, the relative activities of drugs were
assumed to depend only on their binding to receptors:
the more active the dr-ug, the more strongly it was
thought to be bound, doth Ariens and Stephenson
intijduced another parameter of drug activity, the
"intrinsic activity" (Aniens) or the "efficacy"
(Stephenson), both parameters being a measure of the
ability of the drug, once associated with the receptors,
to contribute to the biological response. They differed,
however, in the values which this intrinsic activity or
efficacy could attain, Ariens' intrinsic activity having
a maximum value of 1 for pure agonists, and the value
0 for antagonists, while Stephenson's efficacy could
have any value from zero upwards. They also introduced
the terms "partial agonist" (Stephenson) or "dualist"
(Ariens) for those compounds which were capable of
producing a biological response, but incapable of
producing a maximum tissue response, (as ootained with
a pure agonist), and which could, under certain conditions
antagonise the effects of a pure agonist. These compound!;
have a low efficacy on both theories, and theix* antagonis¬
tic ability seems to be related to their occupation of
receptors which could be occupied more profitably by a
pure agonist. Ariens, however, retained one of Ciax•ic6,
ideas, viz. that a maximum tissue response was produced
only when all the receptors were occupied, and that the
I
response was therefore proportional to the fraction of
receptors occupied. This idea was involved in the
measurement of relative intrinsic activities, these
"being proportional to the maximum responses produced.
Stephenson, however, suggested that all the receptors
need not "be occupied to produce a maximum tissue response,
and indeed that perhaps occupation of a very small frac¬
tion could result in such a response. Thus there could
"be a large receptor reserve. This was demonstrated "by
Nickerson (1956) who showed the presence of a reserve of
histamine receptors in the guinea-pig ileum, using GD-121
(N-1 -naphwhylmethyl-N-methyl-|?)-chloroethylamine) as an
"irreversible" antagonist. He found that an irrevers¬
ible blockade of histamine-induced responses could be
produced by treatment of the tissue with GD-121 for 5
minutes. Increasing the concentration of the antagonist
resulted in a shift of the dose-response curve of
histamine two log. units along the agonist dose-axis
without any significant change in its shape or in the
height of the maximum response. Further treatment with
the antagonist, however, produced a block which was
unsurmountable. In a similar way, Ariens and van
Rossum (1962) showed that GD-121 would antagonise
acetylcholine receptors, and again the log. dose-response
curves, determined in the presence of increasing
-7-
concentrations of antagonist shifted along the log. dose
axis before any reduction in the maximum response
occurred. If a maximum response is usually produced "by
the tissue only when all the receptors are occupied, non¬
competitive "irreversible" antagonists should theoretic¬
ally reduce the maximum response at very low concentra¬
tions .
Stephenson introduced the term "biological
stimulus", S, to avoid making any assumptions about the
relationship between the fraction of receptors occupied
and the biological response.S is given by
S = eY (6)
where e is the efficacy, and Y is the fraction of
receptors occupied. While no assumption is made about
the relationship between S and the effect produced,
it is assumed that equal values of S will produce equal
responses. As an arbitrary standard, the value of S
is given as unity for a 50% response.
The affinity constant of an active agonist cannot
be determined by measuring the 50% response if only a
small fraction of the receptor is occupied, but the
affinity constants of partial agonists can be determined
from "addition" experiments devised by Stephenson. The
method and theory are explained later in the Experimental
-8-
Section,
Ail the theories so far* discussed have been based
on the assumption that the biological response is some
function of the number of receptors occupied by the
drug molecules, and all assume that the response will
be maintained as long as the drug molecules and receptors
are associated. However, Paton (1961) has suggested
that the stimulus may depend, not on actual occupation
of receptors, but on the rate of dissociation of drug
molecules from receptors. Thus an active agonist would
require to have a high dissociation rate constant, while
antagonists would be those compounds whose rate of
dissociation was low, and which would therefore remain
in contact with the receptors for a relatively long
period, thus reducing the probability of another molecule
becoming associated with the receptors. The dissociation
rate constant thus becomes analogous to the efficacy or
intrinsic activity of the "occupation theory".
According to the "rate theory", the maximum effect
of a drug should be seen immediately after its applicat¬
ion to a tissue, at which time the maximum number of
receptors would be available for combination} the
response would then "fade" as the receptors become occup¬
ied, and less available for combination. This "fade"
-9
is often not seen in biological responses unless an
"auxotonic" lever system is used. This was introduced
by Paton (1997) for guinea-pig ileum and has the effect
of increasing the load as contraction of the muscle
increases. The rate theory might be an explanation of
the phenomenon of tachyphylaxis, i.e. the decline in
responses obtained on repeated application of a certain
concentration of drag to an isolated tissue or whole
animal. On this theory, the receptors will be saturated
with drug molecules after the initial application, and
thus subsequent doses will have less chance of combining
with the receptors. However, it has been shown that
tachyphylaxis is not always specific: large doses of
acetylcholine will render the guinea-pig ileum less
sensitive to 5-hydroxytryptamine and histamine as well
as to acetylcholine, and it is known that these
suostances act at different receptor sites.
-10-
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The activity of chemical compounds on biological tiss¬
ues is highly dependent on details of chemical structure,
except for those compounds previously mentioned, whose
actions are physico-chemical rather than chemical. Small
changes in chemical structure, such as the introduction
of methyl groups, or replacement of methyl groups by
ethyl groups, or the choice of an optical or geometric
isomer may affect activity quite markedly, both quantitat¬
ively and qualitatively.
Many iixvestigations have been made Into the effects
of changes in chemical structure on the activities of a
wide variety of compounds, and many conclusions drawn
from the results ootalned. Investigations of this nature
on autonomic stx-uctures are further complicated by the
varied actions of the natural transmitter substance,
acetylcholine. Although this substance is responsible
for the transmission of the nerve impulse across the
neuromuscular junction, at the synapses of autonomic
nerves of ooth the sympathetic and parasympathetic
divisions,and at postganglionic parasympathetic nerve
endings, yet the nature of the receptor sites must be
different, since they require different compounds to
-11-
antagonise the actions of acetylcholine. The action of
acetylcholine at the ganglia and neuromuscular junction
was classified as "nicotinic" by Dale (191U), since its
actions at these sites could oe mimicked by nicotine,
and were blocked by curare alkaloids. The action at
postganglionic parasympathetic nerve endings was classif¬
ied as "muscarinic" due to the similarity to the action
produced by muscarine, these effects are blocked by
atropine.
Investigations into the effects of chemical structure
on the activity of drug molecules have nearly always
taken the form of examination of the changes in activity,
both quantitative and qualitative, which occur as one
proceeds along a homologous series. Almost all compounds
which have high activity in stimulating autonomic struct¬
ures and the neuromuscular junction are characterised by
the possession of a quaternary nitrogen atom containing
three methyl groups, or of a tertiary nitrogen atom
containing two methyl groups. Compounds which have
antagonistic properties usually have larger alkyl groups
attached to a quaternary or tex*tiary nitrogen atom, as
was found by Hunt and Henshaw (1933)» They found that
the ethers and thioethers of triethylammoniurn compounds
•12
had no muscarinic or nicotinic stimulating action, but
most had a "paralyzing" nicotinic action, the latter
action indicated by a failure of nicotine and other
stimulating compounds to produce a rise in blood pressure
in an animal pretreated with the triethyl compounds.
Raventos (1937) studied the actions of four series
of compounds related to tetramethylammonium (TMA) on the
nicotinic receptors of the frog rectus and leech muscle
+
preparations. In one series, RNMe3, where R is a straight
aliphatic side chain containing from 1 to 12 carbon atoms,
his results indicated that the most active compound was
the n-butyl member, which was more active than TMA itself.
Maximum muscarinic activity, as demonstrated on the rat
gut was found in the n-butyl and n-pentyl members, which
+
were equiactive with TMA, Among the series R+N, where
R is an alkyl group from methyl to n-butyl, the only
active stimulant compound was the tetramethyl member,
but antagonism towards the actions of TMA at both
muscax'inic and nicotinic receptors was observed in the
higher members, the intensity of antagonism tending to
increase with increase in the size of the alkyl group.
Progressive ethylation of TMA was found to lead to an
increase in curariform activity on frog nerve-muscle
-13-
preparations, and. to a decrease in muscarinic activity,
as demonstrated on the rat intestine, as far as the
+
MeNEt* compound: the fully ethylated member was antag¬
onistic to TMA on the latter preparation.
Hoiton and Ing (1949) studied the effects of
replacing the three methyl groups on the quaternary
nitrogen of acetylcholine by ethyl groups, or by
aeetoxyethyl groups: these compounds were tested for
their ability to lower the blood pressure of the
anaesthetised cat, and on the guinea-pig ileum, frog
heart and rectus aodoiuinis preparations. They found that
the stimulant activity of the compounds decreased with
successive ethyiation, such that the ethyldimethyl
compound was less active than the trimethyl compound, the
diethylmethyl member was much less active, and the tri-
ethyl member was antagonistic to acetylcholine on the
frog heart. Replacement of two methyl groups by acetoxy-
ethyl groups produced a compound with no stimulant
nicotinic actions, but which antagonised the action of
acetylcholine on the frog rectus. Their conclusions were
that the effects of substitution were due to the removal
of methyl groups from the receptive sites; since the
arsonium and phosphonium analogues of acetylcholine were
-1U-
also less active than the parent compound, this suggests
that the greater atomic diameter of arsenic and phosphorus
effectively increases the distance between methyl groups
and the receptor.
The contribution of the acyl end of the acetylcholine
molecule to its stimulant activity has been studied by
Ing, Kordik and Tudor Williams (1952). They investigated
the impoxtance of the carbonyl and ether groups in a
series of ketone compounds in which the position of the
carbonyl group was changed relative to the quaternary
nitrogen atom, and in a sexd.es of alkyl ethers in which
the position of the ether oxygen was changed. They came
to the conclusion that, in the ketone serdes, the h-keto
compound had maximum nicotinic acetylcholine activity,
this activity decreasing through the 3-keto to the 2-keto
compounds. Among the ethers, which exhibited both
nicotinic and muscarinic activity, the 0-ethylcholine
was the most potent. These active compounds have the
carbonyl and ether groups in the same positions as are
found in the acetylcholine molecule, A comparison of
furfuryltrimethylammonium and 5-methylfurfuryltrimethyl-
ammoniura showed that the latter compound was the more
active, a result which is evidence in support of the
-15-
five atom chain rule. This hypothesis, proposed by Ing
(1949)# on the evidence of various investigators, suggested
that maximum acetylcholine-like activity is found in
compounds which have a quaternary nitrogen atom containing
three methyl groups and a group of five atoms arranged
in a straight chain. The rule was applicaole to aromatic
compounds also if the atoms in the ring were spatially
orientated in such a manner that a five-atom chain were
present. The idea was a modification and extension of
the proposal of Pfeiffer (1948) that cholinergic activity
was closely related to the possession by a molecule of
+ X
three "prosthetic" groups, viz. -NMe3» C = 0, and -0-.
Hey (195P) suggested that maximum nicotinic activity
was found in molecules of the following general structure
+
K-0-CHu.CH2NMe3» and that the electron density of the
ether oxygen was important: he suggested that the
nicotinic activity of such compounds would increase as
the electron density decreased. To demonstrate this
theory, Hey tested a number of phenyl ethers containing
different substituents in the benzene ring (alkyl or
halogen groups), for their effects on the blood pressure
of anaesthetised cats, pretreated with atropine to abolish
-16-
any muscarinic activity. His expectations that the
halogen substituted compounds should be more active, due
to their electron attractive properties, and that the
alkyl derivatives should be less active, due to electron
repulsive properties, were shown to be correct. Hey
also tested a number of esters related to acetylcholine,
+
of the general type R-C=0.0-CHi4CHaNMe<5 , since resonance
could oe expected either between the group R and the
carbony! group, or between the ether oxygen and the
carbonyl group. Activity in such a series should increase
when the group R is such that it enters less readily
into resonance with the caroonyl group, e.g. propionyl
choline should be more active than acetylcholine: the
results from this investigation were not so satisfactory
as those from the phenyl ethers.
A similar investigation was carried out by Ormerod
(1956) who studied a series of benzoylcholine derivatives
in an attempt to gain evidence for a proposal of carbonyl
receptors at cholinergic synapses. His compounds were,
like Hey's, substituted benzene derivatives, the substit-
uents selected being those which had either electron
attractive or repulsive qualities. He found a correlation
between the substituent constant and the stimulating
-17-
potency of the compounds at the cat superior cervical
ganglion, cut at neither the frog rectus preparation nor
the rat phrenic nerve-diaphragm preparation. His
findings, however, were completely opposed to those of
Hey; i.e. the activity of Ormerod's compounds decreased
as the electron attraction of the substituents increased,
Ormerod attempted to explain this discrepancy by the
proposal of a hypothetical carbonyl and ether receptor
at the ganglia.
j R I R )
I k 1 * I
Active ) i ) i
A Surface)- CH3 + 0 = C —> )-CH2 - C - OH, or )-CH=CR*
+ H*0
i R
b y ch3 + o^
' R
His proposed drug-receptor combinations are
illustrated diagrammatically above: the receptor is
visualised as an activated methyl group. In A, the
ganglion surface acts as a undeophilic agent, and will
condense less readily with an electron deficiency in the
0=0 group created by an electron attractive group in
the oenzene ring. In B, a hydrogen bond is proposed for
-18-
ethers. This hydrogen bond will be strongest when the
hydrogen atom is acidic, as it would oe in an activated
methyl group, and when the oxygen atom is most basic, i.e.
when it has an electron deficiency as it would have with
an electron attractive substituent. Results similar to
those of Ormerod were obtained by Wong and Long (1982) in
their experiments on the activity of phenalkyl and
phenacyl trimethylamines. In the substituted phenacyl
compounds, i nicotinic activity decreased as the electron
density on the carbonyl group decreased.
Barlow and Hamilton (1962) attempted to find out
which parts of the nicotine molecule were associated
with activity oy studying compounds related to it. By
comparing the relative activities of nicotine and nicotine
monomethiooide at different pli's, they obtained results
which suggested that the cation was the active form rather
than the free base. Prom an extension of Hey's theory
of the activity of the phenyl ethers of choline, they
suggested that the partially positively charged o<. and
carbon atoms in the pyridine ring might be important
for activity, and argued that the 0 compounds should be
more active than their^ or ^ analogues. In general they
found this to be true, and the quaternary compounds
-19-
p-pyridylmethyltrimethylammonium and. p-pyridylethyltri-
methylammonium were, in fact, highly active on the chick
oiventer-cervicis, rat phrenic nerve-diaphragm, and
cat superior cervical ganglion preparations. The latter
was more than 10 times as active as nicotine on some
preparations. On the rat diaphragm, however, the ^
compound was the most active but there is some doubt as
whether this compound produces block on this preparation
in the same way as the others.
These results can also be interpreted by supposing
that it is a partially negatively charged group which is
important for activity (Sekul and Holland 1961): this
would oe present on the pyridine nitrogen atom,
A different approach to the stuay of substances
with nicotine-like acetylcholine activity was made by
Hrdtman et al, (196b), and by Haglid and Wellings (1963
a,b,c). iirdtman and his colleagues prepared the series
of compounds which would result from the opening of the
pyrrolidine ring of the nicotine molecule at the five
positions possible, A second series of compounds was
O P— CHaNC * , in whichRM
R' and R" were either H,CHS or CaHs.
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In the first series, maximum nicotinic activity
was found, in the pyridylbutyldimethylaro&no compound, and
maximum muscarinic activity was found in this compound
and also in the pyridyl(n-propylmethyl)N methyl compound*
In the other series, the most active member with
both muscarinic and nicotine acetylcholine-like activity
(on rabbit jejunum or guinea-pig ileum, and on cat blood
pressure respectively) was 0-pyridylmethyldimethylammonium,
The conclusions drawn from this work were that the
presence of an alkyl group attached to the carbon atom
joining the pyridine ring and the nitrogen atom caused
a reduction in the physiological activity of the compounds,
No mention was made of any tests done on the intestinal
preparations in the presence of a ganglion blocking agent,
so the nature of the receptors involved is undecided*
another conclusion drawn was that for maximum stimulant
activity in the 3-pyridylmethylamino compounds, one of
the groups k must be CH3 and the other not larger than
CaHj,.
Haglid and Wellings continued this line of investi¬
gation oy varying the nature of the aromatic ring in
R'
the model Ar-CHa-N^ , at the same time as changing
R
the nature of the groups R1 and R", The ring structures
-21-
investigsted were 0-pyridyl, benzyl, thiophene, furan,
pyrrole and indole. 01' these, the 0-pyridyl ring conferred
most activity on the molecule at both nicotinic and
muscarinic receptors, and the most active form of N N R"
was the pyrrolidyl grouping. Further work on pyridine
derivatives suggested that the 0-substituted compounds
were most active on ooth types of receptor, when one
methylene group bridged the ring and nitrogen atom: at
nicotinic receptors especially, the ^-substituted
compounds were most active when the bridge consisted of
two methylene groups.
Mal&sla s£ "^.gv-U,y"; fcS&mUm a£ efUnity ena
eff'toey.
The experiments described so far have been designed
to investigate the activity of biologically active
compounds, ana, with the exception of the work done by
Ariens, no attempt was made to differentiate this activity
in any way.
Measurement of the affinity constants of antagonist
compounds can be made directly by observation of the
concentration required to necessitate increasing the
agonist concentration to produce responses equal to
-22-
doses of agonist acting alone. However, it is not
possible to measure the affinity constants of pure
agonists, since the relationship K is not
valid in this case when only a fraction of the available
receptors may require to be occupied to produce a
maximum tissue response. Replacement of methyl groups
by ethyl groups in the acetylcholine leads to a decline
in agonist activity as shown by Holton and Ing (1949)»
However, lag, Dawes and Wajda (19U5) showed that in a
series of esters of oenzilie acid, which are acetylcholine
antagonists, the compounds with ethyl groups in the
cationic head were actually more active antagonists
than benziloylcholine, and Stephenson (1956) has suggested,
on the basis of these experiments, that the decline in
activity in the agonist series was due to a decline in
efficacy, and not to a decline in affinity. This
suggestion implies that the effects on affinity of
replacing methyl groups by ethyl are the same in both
the acetyl andbenziloyl esters.
To test this assumption Barlow, Scott and Stephenson
(1963) prepared two series of compounds, one of agonists
and the other of antagonists, and measured the affinity
constants of the antagonists and the activity of the
23-
+ +
agonists. The compounds studied were RNMe3, RNMeaEt,
+ + + + + +
RNMeEta, fflttj and RfcNMe3, R1 NMeaEt, R* NMeEta , R1 RKt3
in which R is a 2-(diphenylacetoxy) ethyl, 2-(benziloyloxy)
ethyl, 2—(2,2 diphenylethoxy) ethyl, 3~(diphenylmethoxy)
propyl or 3»3 diphenylbutyrylmethyl group, and R1 is a
2-acetoxyethyl, 2-ethoxyethyl, 3-methoxypropyl or butyryl-
methyl group. The difference between the two groups is
that the first contain a diphenylmethyl group, (or a
benziloyl group) in place of a methyl group. The first
group of compounds are antagonists of acetylcholine,
whereas most of the second group act like acetylcholine.
If the affinity constants of the antagonist series
+ + + +
RKMea, RNMeaEt, RNMeEta, RKEta are denoted by K, K , ^,
K respectively, and those for the corresponding agonist
+ + + +
series k'hMe3, R'NMeaEt, R1 NMeEta, R'NEt3 are K' , K'a,
K'b, K'c, then the relationship between the affinity
constants and the free energy change on adsorption (AF)
is given oy the theory of Arrhenius,
6 F = -RT log Ke
or logi o K = - AF/2.3RT.
The assumption that the effects on affinity of replacing
methyl oy ethyl groups are the same in both the agonist
and antagonist series implies that the change in free
-24-
energy of adsorption depends only on substitution in the
onium group, and that contributions from the groups R
and R1 should be unaffected by such substitution. If
+
then the free energy of adsorption for RKMea is Af, and
+
for Rl NMe3 is Af1 , then the free energies of adsorption
are given oy,
+ +
RNMeaht = Af + a Rl NMeaEt = A. F' + a
+ +
RNMeKta = A F + b R1 NMeEta = A F1 + b
+ +
RKEta = A F + c Rl NEt* = A F1 ♦ c
where a, o and c are the free energy changes for the
substitution of one, two and three ethyl groups respect¬
ively. Since,
log K s (-AF + a)/2.3RT
a
then log(^) = -a/2.3RT.
K
This value should be constant, independent of the nature
of the group R. This ratio should also be the same as
log (K'a/K' ) for the appropriate agonists. If the
+ ♦
equipotent molar ratio for R1 NMeaEt relative to R' NMea
is n, that is, n molecules of the former produce the
same response as one molecule of the latter, then the
biological stimulus causing such a response should be
the same. According to Stephenson (1956) the value of
25-
the stimulus is given by S = eY, where e is the efficacy
and Y the receptor occupancy, and as derived previously
(page ),
eY = eK'A1 (for the first agonist)
and = eaK' A' a (for the second agonist)
The ratio A' a/A' -= n, and thus
e/ea = n K1 a/K'
This ratio of the efficacies can he calculated since the
ratio K'a/K' has been determined from the appropriate
members of the antagonist series. The determinations
of the affinity constants of the five series of antag¬
onists showed, in general, the same pattern. This is
an increase in affinity with replacement of one or two
methyl by ethyl groups, and a partial decline in affinity
when the third methyl group is replaced, although one
or two of the results showed statistically significant
differences between series. The calculations of the
sizes of the differences in free energy changes seemed
to suggest that the incz^eases in affinity are due to
Van der Waal's binding of an additional methylene group.
A consideration of the effects of the nature of the
group R on affinity suggests that these are more
-26.
independent of the nature of the onium group than the
effects of the constitution of the onium group are
independent of the constitution of R, This may be due
to the larger differences in affinity which were measured,
with the consequence that small variations in affinity
are less obvious. The difference in the free energy of
adsorption of the benzilic esters, which were about
twenty times as active as the diphenylacetoxyethyl esters,
suggested the possibility of there oeing hydrogen
bonding between the hydroxyl group of the oenziloyl
group and the receptor. The aiphenylethoxyethyl compounds
had about one-tenth the activity of the diphenylacetoxy¬
ethyl series, and this may indicate that the carbonyl
group of the ester linkage in the latter group is
important for binding to receptors: the change of free
energy measurements between these members suggests that
there may be some electrostatic interaction between either
the partial positive charge on the carbon atom, or the
partially negatively charged oxygen, with appropriately
charged atoms on the recep tor.
In the agonist group of compounds, the effect of
replacing methyl groups by ethyl groups is to reduce
efficacy. In ooth the acetoxyethyl and ethoxyethyl
-27-
series, replacement of one methyl by ethyl group reduced
efficacy by a factor of aoout eight, while replacement
of a second methyl group reduced efficacy about five-
to eight-hundred fold. The replacement of all three
methyl groups by ethyl groups in acetylcholine led to
a slight increase in efficacy, which is inconsistent
with the decline in efficacy seen in other series, and
is difficult to explain.
Examination of the effects of the nature of the
group R on efficacy seems to show that the 3-ether oxygen
atom, as in the ethoxyethyl series,is associated with
a high degree of efficacy, although the corresponding
antagonist series, (diphenylethoxyethyl compounds) have
a low affinity. A 4-ether oxygen atom, however, as in
the inethoxypropyl series, or a 2-keto group as in the
outyrylmethyl series, seem to be associated with a low
efficacy. From these results, the authors suggest that
the action of acetylcholine at postganglionic receptors
in the guinea-pig ileum might depend on the presence of
the U-carbonyl group (and the onium group), for affinity,
and on the 3-ether oxygen and trimethylammonium group
for efficacy.
-28-
The validity of the assumptions made by Barlow
and his colleagues, viz, that the affinity changes in
agonists and antagonists are related to the degree of
ethylation of the cationic head, was challenged by
Burgen (1985), The carbon analogue of acetylcholine,
3#3 dimethylbutylacetate, is only a feeble agonist on
the guinea pig ileum and if the difference in activity
is due only to differences in affinity, Burgen calculated
that the charge on the nitrogen atom in acetylcholine
contributed 5 Kcals/mole to the free energy of adsorption.
The caroon analogue of benziloylcholine on the other
hand, is quite a potent antagonist of acetylcholine,
and has about one-fourteenth of the activity of benziloyl¬
choline, indicating that in this compound the charge
on the nitrogen atom contributes only 1,6 Kcals/mole to
the free energy of adsorption. The charged nitrogen atom,
therefore, is further from the charged group on the
receptor with which it interacts in the latter than it
is in acetylcholine, and Burgen suggests that the ability
of a compound to act as an agonist may depend on its
ability to come close to the charged group in the
receptor. Whether this is true or not, the effects of
-29-
changes in the onium group on affinity will be much
greater in the compounds with high affinity than in those
with low affinity in these circumstances.
These ideas arise from observations with only two
pairs of compounds, and it is important to know whether
they apply to others.
Air, of wohk
1. We wished to check the reproducibility of measure¬
ments of af inity constants of acetylcholine antagonists.
Accordingly we have repeated the experiments performed
by K. A. Scott on the isolated guinea pig ileu.i prepar¬
ation v/ith diphenylacetoxyetiiyl and benziloyloxyethyl
compounds.
2, As the results were found to be consistent, we
extended these two series of antagonists to see whether
changes in chemical structure invariably had the same







3. We wished to see whether we could obtain information
about relationships between chemical structure and
efficacy at nicotine sensitive acetylcholine receptors,
by st 'dying series of agonists and antagonists of
acetylcholine and nicotine on the frog rectus preparation.
To do this, we proposed to test the following compounds,
measuring the affinity constants of the antagonists,
and the relative activities of the agonists:
(i) Analogues of Tetramethylammonium
■f + + + +
, NMejEt, NMeaEta KMeEtj NEt*
V 0 Q Q ® Q
/ / V / \ / V / /
Et Me Me Me Et Et Et Me Et
I + I " I +~~l I + I
\n/
/V / V / \





















(iii) Analogues of Phenyl'-alkyl-trimethyl-ammonium.
h. B.^c.-use we thought that the biological properties
of the compounds might depend, at least to some extent
on the size of the cationic part of the molecule, we
have attempted to obtain information about this by
measuring the electrical conductivity of some of them.
y




1m ££fig Bsg&ia /.bdQmifti? Ezsz&z&him.
Male American Leopard frogs (Rana pipiens) were
killed and the rectus abdominis muscle was diesected from
the pelvic girdle to its insertion in the cartilage of
the pectoral girdle. The muscle was then divided longi¬
tudinally into two halves, each of which was used in a
separate experiment. The stripe of muscle were tied with
a loop of thread at each end, and suspended in an organ
bath containing Clark's Ringer at room temperature and
gassed v/ith atmospheric air from a i'airey aerator.
I
j Recordings of the contractions of the muscle were made
.
by a gimbal lever writing on the smoked drum of a kymo¬
graph, the load being l-2gm depending on the size of)







2. Gttlngja Eije Aeuro, Preparation
Guinea pigs of either sex, weighing between 150gm
and 250gm, were starved for a period of 12 to 18 hours
preceeding the experiment. They v.ere killed by a blow
on the head and bled out. The abdomen was opened and the
terminal portion of the ileum was carefully dissected out,
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excluding the region containing the large Peyer's patch
immediately adjacent to the junction with the caecum.
I
The ileum was dissected free from the peritoneal membrane
great care being taken to avoid any stretching of the
tissue, and then placed in Tyrode solution previously
warmed to 37°C. Warm Tyrode was found to facilitate the
irrigation of the intestinal lumen which was occasionally
necessary. If the tissue was placed in cold Tyrode
solution, this usually resulted in a contraction of the
muscle, especially the circular layer, with a resultant
hindrance to fluid flow.
Care was also taken during the washing stage not
to exceed pressures of more than 3 to i+cra of water
because this distends the tissue and tends to induce
spontaneous contractions.
Lengths of 3-Ucm were then tied at each end, making
sure that the lumen remained patent, and suspended in
Tyrode solution at 35UC. Contractions were recorded
on smoked kymograph paper, using an isotomic frontal
writing lever with a load of 0. 3gnk Hexamethonium bromide
was added to the Tyrode solution in a concentration of
2.76 x 10~*M to reduce spontaneous rhythm, and to ensure
that the action of compounds under test was at the
postganglionic parasympathetic nerve endings. The










The experiments (on ooth tissues) were designed to
measure changes in activity (agonist or antagonist
activity) resulting from changes in chemical structure at
both "muscarinic" and "nicotinic" acetylcholine receptors.
With a few exceptions, all the experiments were performed
using automatic apparatus.
fponjLsts
The automatic apparatus consisted of one machine
capable of adding drag solutions either singly, or
in the order of Latin squares, three different forms of
which were programmed into the machine. This was used
in all guinea pig ileum experiments which were based on
a ninety second cycle, the drug being in contact with
the tissue for 15 seconds, then washed out twice with
Tyrode solution by overflow: the overflow method was
preferred to drainage of the organ bath and refilling,
since the latter method exposes the tissue to air and a
lower temperature, and also causes artefacts in the
responses written on the smoked kymograph paper.
Preliminary experiments were performed by adding the
test compound to the organ bath from a pipette in order
-36-
to determine those concentrations which would be necess¬
ary to produce responses which lay between 25-75/6 of the
tissue maximal response. The standard agonist, either
acetylcholine or carbaehol, was added in a similar way
and log.dose - response curves for the test compound
and for standard agonist were plotted and compared.
These were nearly always found to be parallel (for true
agonists) and thus results from a 2+2 assay should be
valid. The four different agonist solutions were added
in the order of three Latin squares as mentioned above,





This dose order is so arranged that each dose follows
every other dose the same number of times, and thus it
was hoped that the effects of one dose upon another
,
would not be likely to bias the results. Two machines
,
were used for experiments on the frog rectus preparation:
each was capable of adding one of three drug solutions
either singly, or in a predetermined order (A,B,C,A,B,
C etc., or A,A,B,B,C,C, etc.,) while one was also pro¬
grammed to add four drugs in the following order:-
-37-
A B C D
A D c B
C D A B
G B A D,
If A and C are low (high) doses of standard and test
compounds, and B and D are high (low) doses of standard
and test compounds, then this form will alternate high
anu low doses. This design was found to be necessary
for the rectus preparation because of the inhibiting
effect of a large contraction on a following large
contraction. Thus 2+2 assays could be performed on
this machine following similar principles as for the
ileum experiments. Bracketing assays (2+1 assays)
could be performed on the other machine which was not
programmed to perform 2+2 assays.
The standard agonists used for comparison in all
assays were either acetylcholine iodide or carbachol
chloride on the ileum prepai*ation, and tetramethyl-
ammonium iodide or p-pyridylmethyltrimethylammonium
bromide on the frog rectus preparation. The use of
nicotine as standard agonist for the rectus preparation
was abandoned oecause of the excessively long time
necessary for the tissue to relax after an effective
dose. Several other compounds tested, particularly
tertiary amino compounds, were also difficult to wash
-38-
out of the tissue, and the length of the cycle of
operations had to he lengthened appreciaoly, A ten
minute cycle with a drug contact time of 1st minutes
was sufficient for most of the quaternaryammonium com¬
pounds, Out the tertiary compounds mentioned above, and
also nicotine monomethiodide (which is permanently
ionised), required a 30 minute cycle, with a ki minute
drug contact time.
Antagonist
Antagonistic activity of pure antagonists was
measured as the affinity constant of the compounds for
the tissue receptors. The constants were obtained from
the Gaddum equation (1937)
IKJ_ - /_B_/ Kb
L»J
Where the response to a concentration / A_/ of pure
agonist in the presence of a concentration / B_/ of
antagonist is equal to the response produced by a
concentration / a_/ of the agonist acting alone. Ks
is the affinity constant of the antagonist.
Two different types of experiment were performed on
the ileum.
a. A concentration of acetylcholine, (or carbachol)
was applied to the tissue regularly (every 90 seconds
for 15 seconds) until the responses became regular.
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Two other concentrations of agonist were then selected
so that there was a dose difference of 2x between each,
and groups of five contractions were obtained with each
concentration applied in a random order until the
responses became regular. The Tyrode washout solution
was then replaced by Tyrode containing a concentration
of the antagonist which, from preliminary mannual
experiments, had been found to exhibit a convenient
degree of antagonism. The agonist solutions were replaced
by a solution of the same concentration of antagonist
as in the washout, together with a higher concentration
of agonist. This concentration was chosen so that the
responses would lie close to the height of the responses
produced oy the middle concentration of agonist alone.
This solution was then applied repeatedly to the ileum
until five responses of the same height were recorded,
when it was assumed that the antagonist had come into
equilibrium with the receptors. A higher concentration
of antagonist with a correspondingly higher concentration
of agonist was then used, and the process repeated.
Finally a third concentration of antagonist and agonist
were used so as to ootain eventually responses in the
presence of three concentrations of antagonist.
The concentrations of agonist, which would alone
produce the same responses as the equilibrium responses
-40-
in the presence of the different antagonist concentrations,
were then calculated either graphically or algebraically.
From these concentrations, the affinity constants could
]
oe uetermined from equation ( k ). Since this equation
holds only for competitive antagonism, then a graph of
(A/a - 1) against / B_/ should give a straight line
passing through the origin* this was used as a test of
the nature of the antagonism.
The other method used to determine the affinity
constants relied on the same Gaddum equation, but the
technique was slightly different. Two concentrations
of standard agonist which produced responses between
25-75?" of the tissue maximum were applied alternately
to the ileum until the responses became regular. These
solutions were then replaced by higher concentrations
of the agonist in the presence of an antagonist, the
concentrations being those which from preliminary
experiments were calculated to produce responses very
similar to those obtained in the absence of antagonist.
These concentrations were then applied alternately until
regular responses were recorded. The responses were
then compared as in a 2+2 assay, arid the dose ratio
I produced by the antagonist concentration calculated.
The value for was then calculated as oefore. The
advantage of this method is that it shows quite clearly
MEASUREMENT OP THE AFFINITY CONSTANTS OF ANTAGONISTS,
The f igures iranediately "below the responses are the
concentrations of p-pyridylmethyltrimethylammonium
producing each response. At the arrows the antagonist
-pyridylethyldiethylammonium) was added in the
Doncentrations shown.
FIGURE IA.
MEASUREMENT OF THE AFFINITY CONSTANT OF A PARTIAL
AGONIST. (RECIPROCAL PIOT METHOD ).
Responses of the frog rectus to concentret ions of
tetramethylammonium, 1, 2, 1+, and 8 x 10~"-*M, (A^ , Ag,
A-rt 811(1 A, respectively), and to methylpyridinium, 3,
D 4
6, 12, and 21+ x 10""5M, (P^ , P2> P^» and respectively).
The compounds were left in contact with the tissue for
1+5 minutes. The drum was stopped for 23 minutes during
the washing and recovery period so that the interval
"between doses was 30 minutes.
GRAPH OP 1/a AGAINST 1/p CALCULATED PROM THE RESULTS
SHOWN IN THE TRACING.
-Kp Vp x 102
FIGURE IB.
MEASUREMENT OF THE AFFINITY CONSTANT OF A PARTIAL
AGONIST (ADDITION METHOD).
Responses of the frog rectus to concentrations of
tetramethylammonium and ethylquinuclidinium. The time
cycle of events is identical with that described for
Figure IA.
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whether the slope of the dose response curve of the
agonist lias been altered by the antagonist, and may
indicate whether or not the antagonism is competitive.
The expex'iments on the frog rectus preparation were
essentially similar to those on the ileum, except that
the initial doses of agonist alone were alternated singly,
ana not in groups of five, because of the length of the
time cycle. Sometimes three doses of agonist were
applied in the presence of the same concentration of
antagonist in order to get a clearer picture of any
change in the slope of the log.dose-response curves.
Some of the compounds with agonist activity were
found to have aose-response slopes which were consider-
aoly shallower than those for the true agonist standard.
In these instances, it was found that the maximum
contraction produced by the drug was less than the
tissue maximum, (or maximum for the true agonist). These
compounds were therefore tested for partial agonist
activity by one of two methods. The first of these is
the addition method as devised by Stephenson (1956),
which consists of finding a concentration, At , of true
agonist, of efficacy and affinity K^, which is the
equivalent of a dose, P, of partial agonist, with
efficacy e? and affinity Kpf and a concentration, As
-U2-
which produces the same response as P and A3 acting
together.
For an agonist in equilibrium with the receptors,
Agonist + Receptors Complex
Z\y + /~1 - Y_y ^ Y (see page 2 )
*2
ana K(A) = -
1-Y
If the agonist is highly active, and Y is therefore
small, 1-Y approximates to 1, and thus
Y = KA.
If the partial agonist occupies a fraction, x, of the
receptors, then, according to Stephenson, the response
is due to a stimulus (S)
S = epX
where ep is the efficacy of the partial agonist. Now
since the concentration P of partial agonist produces a
response equal to / Ai,_/ of true agonist, then the
stimuli must be equal. Thus,
S» = epX = eAKA /"AtJ
Thus,
epX = eAKA/A,_7
The response to (P + A3) is produced by a stimulus
Ss> = eaKA = epx + eAKA (l-x)
-43-
>l£,
tl»«uining that values of S are additive and that the
active agonist occupies only a negligible proportion of
receptors whereas the partial agonist occupies a signifi¬
cant proportion. Thus,
eaKa(Aa) = e&Ka(Ak^ * eAKA^) ^1~x)
Slid T „ Aa — I1—X = ■
Aa
Values of x can be calculated for different concentrat¬
ions of partial agonist and Kp calculated from
Kp.P. =r
1—x.
Experimentally the procedure was to choose two
concentrations of true agonist which were expected to
lie on the linear part of the log.dose-response curve.
The concentration of partial agonist chosen was such as
would produce a response a little higher than the smaller
response to the true agonist. This concentration of
partial agonist was then applied to the tissue together
with sufficient of the true agonist to produce a response
which was just smaller than the larger of the two true
agonist responses. Thus the equivalents of P and
(P + As) could be calculated by interpolation from log.
dose-response curve of the true agonist.
The second method of measuring the affinity constants
of partial agonists was also developed by Stephenson.
-i+4-
This depends on the assumption that the partial agonist
occupies a significant proportion of the receptors when
producing a response, whereas the true agonist occupies
only a small proportion of the receptors.
Thus if a concentration a of true agonist (of
efficacy e^ and affinity constant K^) produces the same
response as a concentration P of partial agonist (of
efficacy e and affinity K), then, again assuming that
-Cr Jr
equal "biological stimuli produce equal responses,
c „ e.K.a e K PS = eY = A A = p p
1+aKA 1+PK
e K a.
As "before A A reduces to e^a if only a very small
1+aKA
proportion of receptors are occupied "by the true agonist.
P
Thus, eAKAa = W
1 ♦
Prom this it follows that,
1 = GAKA (1) ,eAKA j
a
4 ePKP P ®P
against p
and a graph of will produce a straight line with an
■\
intercept of - K when = 0. Experimentally this
p a
method consists of producing responses to graded doses of
true agonist and of partial agonist, and finding the
equivalents of the partial agonist concentrations by
-US-
interpolation from the log.dose-response curve of the
true agonist. This was sometimes done in the form of a
series of bracketed doses, or occasionally by performing
a form of 2 + 2 assay} 2 responses to concentrations of
the true agonist were matched with responses to 2 concenr
trations of partial agonist} the difference from a real
2+2 assay being of course the disparity in the concen¬
tration difference between low and high concentrations of
the same drug.
The values for 1 and 1 were then calculated and K
it 9
determined either graphically (if more than two concen¬
trations of partial agonist were used), or algebraically
(if only two concentrations of partial agonist were
tested),
a&BLfca i'pr 'vWje.UUve hfltfcagjaiaiB
If an agonist is producing responses in a tissue in
the presence of two antagonists, the following equilib¬
rium situations will arise:-
A + R * AR A is the agonist
B + R BR B " " competitive antag¬
onist
C + R ^ ' OR C M " antagonist under
test.
—h6-
If the proportion of receptors occupied by the agonist
/~ARJ is given as y, and x and z are the proportion
of receptors occupied by the antagonists /~BRJ and
/"CR_7 respectively, and if the respective affinity
constants are KA, Kg and Kc, /~A_7, /~*B_7, /"~CJ7 being






Thus, y_ = x = z
AKa Kj, 0K0




so AKa - yiiKA - yBKg - yCKc = y
i.e. AKa = y— (i + B1r + CK )
1 - y
If the response produced by a concentration & of
agonist alone is the 3ame as that produced by of
agonist in the presence of B, by A of agonist in the
—S.
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presenee of C, and "by A^Q in the presence of both B and C,
A^ = 1 + BKg} A, = ! + QK^ A^ = i + BKg + CKq
a a a
so ite-I ♦ CKC .!♦ dags ra.Uc toy, c aloag - 1
1 + BKg dose ratio for B alone
ri.e. dose ratio for BC =* dose ratio for B + dose ratio
for C-l, where all dose-ratios are calculated by comparis¬
on with the responses produced by the agonist alone (a)J.
Example: if B (alone) produces a dose ratio of 100 and
if C (alone) produces a dose-ratio of 10,
J&£ - x + = 1.09
A^ 100
If C is not a competitive antagonist and the s-abstances
A and B do not displace it from the receptors, the value
of z will depend only upon the concentration of C so,
CK„
CKC = —^— and z =





and as AKA = —2£— # the dose ratio for C, A = 1-y
1 * y t
1+GKC
-k8-
When the truly competitive antagonist B is present as well
-V
_ x
, as "before, and AK^ = y
kA "**B 1 - y - x - z
AK,. BKg
i-y-!2a-2a
AK 1 + CKC
So
so y = MA - yAKA - yBKB - AKaCKQ,
1 + CKq
and AKa(1 - y - CKC ) = y(l + BKg).
1 + CKQ
\cka - y(1 - BV whereas A^KA = ——2L-—.(l+BKg)




_ l - y which is the same as the dose
i - y - ratio for C alone.
1+CKC
.-hen ^ _ ^00 ^ ^as in exampxe^f A-bc will
equal 10 not 1.09. The distinction is even more clear-
cut when the dose ratio for C alone is higher (e.g. for
25, the contrast would he "between 1.21+ and 25) •
Experimentally this test was applied only to antagonists
on the frog rectus preparation, using tuhocurarine as the
-U9-
known competitive antagonist. Suitable responses to a
standard agonist, either carbaehol or p-pyridyl-methyl-
trimethyl-ammonium bromide were obtained in the absence
of curare, then in the presence of sufficient curare to
necessitate increasing the agonist concentration by a
factor of 100 or more. A further series of responses
were then obtained in the presence of the same concen¬
tration of curare plus a concentration of test antagonist
which from previous experiments had been found to produce
a dose ratio of about 10, The responses in the presence
of both antagonists were then compared with the responses
in the presence of curare alone, and the nature of the
antagonism determined as previously mentioned.
Msasmsffisfl&a
The electrical conductivity of the drug solutions
was calculated from the reciprocal of the resistance
measured by a Phillips Conductivity Bridge GM 2+2i+9 and
conductivity cells - types PR 9510 and PR 9513/00, The
bridge consists of a Wheatstone Bridge using a current
alternating at 50 or 1000 c/s, the resistance measured
being that of the volume of solution between two parallel;
platinum plates in the conductivity cell.
The experiments were carried out in Quickfit and
quartz stoppered tubes suspended in a thermostatically
-50-
controlled tempersture bath of deionised water, which
was supposed to be 25° ±. 0.1°C,
All solutions were made up in deionised water
freshly collected from an Elgastat Deioniser, the
_e
conductivity of the water being about 1 x 10" mhos-
cin. . Three concentrations of each drug were tested,
these usually being 1 x 10"®M, 1 x lO^M and either
5 x 10~4M or 1 x 1Q""*M. The technique usedv^as as
follows:- the conductivity cell, normally stored in
deionised water, was rinsed in a tube of freshly
collected deionised water and allowed to remain in one
for 15 minutes between each 1est« About 10cc of each
concentration of drug solution were edded to four
tubes which were then stoppered to exclude C02 and
allowed to come to temperature equilibrium in the water
bath. The conductivity cell was placed in one of these
for 15 minutes to allow ions adsorbed on the platinum
back to equilibrate. The cell was then transferred to
one of the other tubes containing the same concentration
and left for 2 minutes before jaeasuring the resistance
of the solution. This process was repeated for the othe
two samples of the concentrations, and the mean of the
three readings taken. The conductivity cell multi¬
plication factor was checked before any experiments
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were carried out. This was done toy measuring the
resistance of a solution of potassium chloride, the
specific resistance of which is aceux-ately known.
Analar grade KC1 was oven dried to remove any traces
of water, and a solution exactly 1 normal was made uo
50
in deionised water. The resistance of this solution
was measured at 25 ± 0.1°C. The multiplication factor
C of the cell could then toe fouxid by reference to tables
of the specific resistance of KC1,
p
C =
p where p = specific resistance in
ohm-cm. R = obsex'ved resistance.
The multiplication factoz- was found to be 1.331 for cell
PR 9510, axid 0. tot>5 for all PR 9513/00.
The specific conductivity K of the drug solutions
is therefore calculated as K =
for dilute solutions, the conuuctivity of the
solvent becomes important. Thus K = ^ ^ ) where
Re = measured resistance of solvent.
The molar conductivity of a solution ( f\) is given by
A = Where x = concentration in gm moles/litre
i e _ IQQQ. .1/1.1)"
x C *F. R0;
Difficulty was experienced in obtaining consistent
results for most compounds and at length this was
discovered to be due to the inaccuracy of the thermostat
apparatus. This was found to be incaxxable of maintaining
a temperature within +, O.l^C, and flue tun uioxis of
± 0.5 - l.C^C were sometimes recorded. This temperature
variation might be sufficient to cause a scatter or 2-3%
in the mean values obtained, and unfortunately this
difference was of the same order of magnitude as the




The i*esults of the affinity constant deteimiinations
are given in TaDle I. For comparison, the results
obtained by K. A. Scott are included, and in all instances
with the exception of the dimethylethyl member of the
diphtqyUacetoxyethyl series, the two sets of results are
not significantly different on statistical analysis
(?>0.2).
In the first four members of each series, the
affinity increases with the replacement of one methyl
by ethyl, but the replacement of a second methyl by
ethyl has little further effect. The affinity of the
fully ethylated compounds is, in both series, lower than
that of the preceding diethylmethyl member. The
consistency of the two sets of results would appear to
indicate that the method yields reproducible information.
The results for the additional members of these series
are also shown in Table I. The affinity of the members
of the benziloyl series increases as the methyl group is
replaced by an ethyl group, and the pyrrolidine
compounds have a higher affinity than the piperidine.
I
M 2H MATURE OF OHIUM GROUP ON AFFINITY FOR RECEPTORS
IE asm
Values given are log. affinity constants with standard errors;
figures in brackets indicate the number of tissues used.









7.159 0.003 (4) 7.171 0.014 (5)
7.582 ± 0.025 (7) 7. 643 ± 0.017 (4)
7.584 ± o• o -J CO (4) 7.489 0.025 (4)
7.566 ± 0.063 (4) 7.431 ± o• o roo (14)
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/ 7.015 ± 0.054 (4)
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Benziloyl series

















>Q 8.656 ± 0.012 (5)
8.088 x 0.050 (6)
•f /
/N\__/ 8.125 x O.Oi+O (5)
K.A.S.
8.494 0.019 (5) 8.535 ± 0.045 (5)
8.934 .t 0.030 (7) 8.937 Jb 0.010 (6)
8.969 0. 038 (7) 8.952 0.032 (8)
8. 664 X 0.034 (5) 8. 671 J: 0.071 (3)
Et
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Values for true agonists are equipotent molar i>atios relative
to tetramethylammonium and are doubly underlined; values for
partial agonists are log. affinity constants and are singly
underlined: values for true antagonists are log. affinity
constants, and are not underlined. All values are given with














2.09 ± 0.11 (10)
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6.75 ± 0.76 (7)
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5.46 ± 0.12 (5)
Et
3.023 ± 0.092 (9)
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derivatives. In the diphenylaeetoxyethyl series, how¬
ever, replacement of methyl by ethyl in the piperidine
compounds reduces affinity, while the afrinity changes
in the pyrrolidine members are similar to the correspond¬
ing members of the benziloyl series.
Maximum antagonistic activity in both series is
associated with the dimethylethy1- and diethylmethyl-
ammonium compounds, and the piperidine compounds have the
lowest affinity for the receptors.
In general, although the results with the first
four members of the series are remarkably similar, those
with the second four members are clearly different.
Ji. on.iu.ip gggffiaua&s*
The results for these compounds are shown in Table
IIA. In all instances, the replacement of methyl groups
by ethyl groups tends to reduce agonist activity, and
sometimes leads to purely antagonistic activity.
A progressive change, both quantitative and
qualitative, is seen in the compounds of group (i).
Replacement of methyl by ethyl leads firstly to a red¬
uction in agonist activity as is shown by the increasing
values of the EPMR's as far as the dimethyldiethyl
compound: the triethylmethyl compound is a partial.
M£ IIS
gsMmisaa ql MTOS m ss mrc
msim QF. ^wim
Values given are log. affinity constants with standard errors.
Figures in brackets indicate the number of tissues used.
ADDITION METHOD RECIPROCAL PLOT METHOD
2.392 ± 0.114 (6) 2.560 * 0.053 (3)






2.631 ± 0.082 (4) 2.357 ± 0.046 (4)
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agonist, while the tetraethyl member is a pure antagonist
with a higher affinity than the partial agonist. A
similar change is observed in group (ii). The first
substitution of methyl for ethyl reduces agonist activity,
v/hile thw c.iwthyl pyrrolidinium is a pure antagonist,
but none ol the 11embers of this group is a partial agon¬
ist.
The i orjfiilium derivatives in group (iii) show a
change from ~ure agonist to a partial agonist and then
to a pure antagonist, the affinity of the latter being
again higher than that of the partial agonist.
The L\ o gyridinium derivatives of group (iv) are
both partial agonists, but here the replacement of methyl
by ethyl lies no significant effect on the value of the
affinity ro-htant.
The ruinuclidinium compounds of group (v) show a
qualitative change from pure agonist activity to partial
antagonism vnen the methyl group is replaced by ethyl.
Table lib ..hows a comparison of the results obtained when
/he affinity constants of three partial agonists were
measured by the two methods mentioned previously. For
two compounds the choice of method has no apparent effect
on the mean values obtained when these are compared
TABLE III
ACTIVITY OP PYRIDINE DERIVATIVES ON FROG RECTUS PREPARATION
Values for pure agonists are equipotent molar ratios relative to
p-pyridylmethyltrimethylammonium and are doubly underlined:
values for partial agonists and pure antagonists are log.affinity
constants, the former being singly underlined, the latter not
•underlined. All results are given with standard errors: the
figure in brackets indicates the number of tissues used.
€p(0H2)nE
n = 1 a 0
R NMe3 - 1
NMe0Et - 30.0 ± 5.0 ( )'2
'2
+
NMeEt9 - 3.678 ± 0.097 (6)
+■
NEt^ - 3.681 + O.O97 (6)
NMe,, weak agonist 176.8 ± 6.8 (7) weak agonist
NEt2 3.019 ± 0.050 (1+) 2.611+ + 0.11+8 (1+) 3.273 ± 0.012 (8)
NnPr2 3.738 ± 0.037 (6) 3.719 ± 0.080 (8) 1+.137 ± 0.110 (6)
NnBu2 - 1+.363 + 0.106 (1+)
N~~\ 2.80 (l) 21+.0 ± 1+.0 (1+) 3.093 ± 0.133 (3)
v_y
TABLE III continued.
n = 2 a p Y
R NMe2 - 21+2 ±35 (5)
KEt2 3.405 ± 0.053(4) - 3.332 ± 0.093 (3)
NnPr2 3.8 (l) 3.216 ± 0.014+ (7) 3.949 ± 0.054 (3)
NnBu, TOXIC
152 ± 12 (5) 3.555 ± 0.173 (1+) 198 ± 22 (1+)
n = 3
WMe^j 3.1+08 ± 0.130 (6)
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statistically♦ The results ob.ained for the ethyl-
pyridinium compound, however, are significantly different
P = 0.05 - 0.02.
III. Py.'idine Ana lo ues.
Tlx. results for the pyridine analogues are shown in
Table III, The results for the first four compounds in
this i'o in, the quaternary p-substituted pyridylmethyl-
ammonium compounds, show a range of activity which is
qualit; Lively similar to group (i) of Table IIA, the
compourh: changing from pure agonists, to a partial
agonist and finally to a pure antagonist when all three
methyl roups are replaced by ethyl groups. However,
the afxhiity of the triethyl compound does not differ
signili-. ally from that of the diethylmethyl derivative.
In c.ic tertiary, dialkyl, compounds which are
antagonists, three observations are of interest. First,
an increase in the size of the alkyl group invariably
increases the affinity of the compound. Second, the
P-subcfcituted compounds have a lower affinity than the
a- oi'T- isomers. Third, the effects of lengthening
the methylene chain are variable: in three instances,
lengtneiip the chain increases affinity, while in two
instant,-s the affinity decreases.
TAPka U
ACTIvITY OF PHENYL DERIVATIVES ON FRGG RECTUS PRxPAkATION
Values for pure agonists are e^uipotent molar ratios relative
to p-pyridylmethyltrimethylammonium and are doubly underlined;
values for partial agonists and pure antagonists are log,
affinity constants, the former being singly under-lined, the
latter not underlined. All results are given with standard
errors; the figures in brackets indicate the number of tissues usee
<2>(CH2 )nNR3
R = Et
4.033 ± 0,01+6 (7)
3.394 jl 0.155 (4)
3.991 ± 0.066 (3)
5.079 j; 0.036 (4)
5.103 ± 0.053 (5)
R = Me
0 55.9 ± 2.0 (6)
1 92.4 ± 8.4 (6)
2 11.2 ± 0.1 (4)
3 3.8 ± 0.3 (4)
4 41.0 +3.1 (4)
5 16,a ,+ 0,8 (8)
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The activity of the p-pyridylalkyldimethylammonium
compounds decreases as the length of the methylene chain
increases, the fS-pyridyl-n-propyldimethylamrnonium
compound being a pure antagonist.
IV. -.-ony1 Derivatives
1h^ results for these compounds on the frog rectus
preparation are shown in Table IV. In the trimethyl-
ammouion series, maximum agonist activity is found in
the compound with the trimethylene chain, but there is
110 obvious relationship between activity and chain
length. There is also an apparent lack of correlation
between activity and chain length in the triethyl-
ammonium series, the compounds with ' ethylene and
trimctuglene chains showing partial agonist activity,
while the rest of the compounds are pure antagonists.
In this caries, the affinity decreases as the methylene
chain increases from one to two carbon atoms, but then
rises again with further increase in chain length.
On tne guinea pig ileum preparation, the pattern
of results is quite different, as is shown in Table V.
In the trimethylammonium series, maximum agonist
activity is found in the benzyl derivative, while the
TABLE V
ACTIVITY OP PHENYL DERIVATIVES ON GUINEA-PIG ILEUM PREPARATION
Values for pure agonists are equipotent molar ratios relative to
0-pyridylmethyltrimethylammonium and are doubly underlined:
values for partial agonists and pure antagonists are log.affinity
constants, the former "being singly underlined, the latter not
underlined. All results are given with standard errors; the
figure in "brackets indicates the number of tissues used.
R = Me
n = 0 27,60 ± O.99 (5)
R = Et
1 2.11+ + 0.11 (U) *4-831 ± 0.011+ (4)
2 6.11+ + 0.85 (5) I4-9I47 ± 0.01+6 (5)
3 18.8 ± 1.10 (6) 5.185 ± 0.050 (8)
4 4.771 ± 0.060 (1+) 5.480 ± 0.031 (4)
5 5.198 + 0.013 (8) 5.768 + 0.012 (6)
TABLE VI
EFFECTS OF SUBSTITUTION IN BENZENE RING ON ACTIVITY OF FHENYL
COMPOUNDS ON FROG RECTUS PREPARATION
Values for pure agonists are equipotent molar ratioB relative to
0-pyridylmethyltrimethylammonium and are doubly underlined:
values for partial agonists and pure antagonists are log.affinity
constants, the former being singly underlined, the latter not
underlined. All results are given with standard errors: the
figure in brackets indicates the number of tissues used.
R as Me $ y R = Et 0 y
X = SI 38.35 ± 0.95(3)
NO2 3.722± 0.108(4) 2.72(1) 4.325 ± 0.035(5) 4.130 + 0.059(5)
H 92 4.033 $ 0.046 (4)
ms m
££M Qr\ flJggTITmQfl III M£ PIMfl. Off ^SlimX stf
mm mm qw axam=m ILM mmai.
Values for pure agonists are equipotent molar ratios relative to
{3-pyridylmethy1trimethylammonium and are doubly underlined:
values for partial agonists and pure antagonists are log. affinity
constants, the former being singly underlined, the latter not
underlined. All results are given with standard errors: the





X = NO2 (1) -
CI (1)
4.159 ± 0.016 (6) 4.334 ± 0.037 (8)
5.034 ± 0.018 (9) 5.119 ± 0.023 (7)
r
H 2.29 _t 0.19 (5) 4.817 ± 0.018 (4)
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phenyl-n-butyl and phenyl-n-pentyl compounds are pure
antagonists. There is no intermedinte partial agonist
in this series, out the aidinity of the antagonists shows
an increase with increase in chain length.
The trie thy laminonium compounds are all pure antag¬
onists, and the affinity increases ^uite regularly with
increases in the length of the methylene chain.
In i^oles VI and VII «_n-e shown the results of a
few exjeriments using phenyl compounds with substitutions
in the uenzene ring. On the frog rectus preparation, the
substitution of a nitro group in either the a- or im¬
positions of the ring of trimethylammoniura compounds
produces compounds which are partial agonists, the a-
suostituted compound having a higher affinity than the
p.- isomer. In the triethylariimoi-ium compounds, euostitut-
ion oi a nitro gz»oup at the or p- positions leads to
an increase in affinity, the &- compound having a higher
afxinity than the p- isomer as before.
duostitution of a chloro group in the &- position
of the trimethylammonium compound causes an increase
in agonist activity.
On the guinea pig ileum prepaiation the efrects
of substitution of a nitro group into the benzene ring
TABLEVIII
RESULTSOPTESFORCOMPETITIVEANTAGON SM D/RCurare/ompound/CurareompetitiveN n-c mp titive +compound.D/R/ .
j^j|CH2NnBu279.83..231.053 8 CH2Nr£Pr285.44.652.921.034 65 ^jCH2fek3113.03.045323 1+ 943.041 52.3.04 Firstcolumnshowsthedo e-ratio(D/R)produced"byc rareact nglo e* Secondcolumnshowsdo e-ratiopr duced"bympoundalo e* Thirdcolumnshowsdo e-ratioproducedbythantagonistsc ngtogether* Thefinaltwocolumnssh wtthe reticaldo e-ratiosf rcompetitiveantagoni m andnon-competitivea tagonismrespect vely.
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are y.uite different from those on the frog rectus. The
result is a decrease in affinity, and the isomer is,
in this instance, the more active of the two tested.
The chloro-suostituted compounds, however, show a similar
activity to that on the rectus, viz. an increase in
affinity, out the p.- isomer is the more active.
In the trimethylaimnonium compounds, the introduction
of a nitro group reduces the agonist activity consider¬
ably, while the introduction of a chlorc group also
reduces agonist activity, but not to the same extent.
1m for Coir.psUUvs Mteaaijaa
The results of four tests for competitive antagonism
are shown in Table VIII. If a compound is a competitive
antagonist, then the dose ratio proauced by the compound
and curare together should be just above one. If the
antagonist does not act competitively, then the dose
ration of the combined antagonists will be the same as
that of the test compound acting alone. 0-pyridylmethyl-
di-n-butylammonium thus appears to be a non-competitive
antagonist, but the nature of the antagonism of the
other compounds is not so clear. It is likely, however,
that some degree of competitive antagonism is present.
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Repetition of the testing of some of the compounds
studied by K, A. Scott (Table I) indicates that the
method gives reasonably consistent estimates of the
affinity constant. The results for diphenylacetoxyethyl-
dimethylethylammonium are apparently significantly
different from those obtained by K, A, Scott at a level
of probability of about 0.02, but the difference is small.
In view of the rather small number of estimates ODtained
by Scott, it is quite possible that the difference
simply arises from sampling error, and a reason for
believing this is that the new results are more consistent
with those obtained in other series. The variance of
the estimates is of the same order as that obtained by
Schild (19U7)» with measurements of pAg, and by K. A,
Scott (19b2) and by Mustafa (19&7).
Although the effects of replacing methyl groups by
ethyl groups in the two series of compounds, the benziloyl
and diphenylacetyl esters, are vex1y similar (Table IX ),
the effects of replacement by other groups are not the
same in the two series. Thus the first part of the table
justifies the belief that it may be possible to estimate
changes in the affinity of series of agonists by studying
TABLE IX
EFFECTS OF COMPOSITION OF THE ONIUM GROUP ON AFFINITY
Values given are A log.K which is equal to log.K -log.K for— 8.
the fully methylated compound,
Diphenylacetoxyethyl Benziloyl
$Me2Et 0.1+23 ± 0.025 (7) 0.1+1+0 + 0.030 (7)
&MeEt2 O.U25 + 0.078 (1+) 0.1+75 + 0.038 (7)
NEt, 0.207 + 0.063 (U) 0.170 + 0.034 (5)








0.1+05 ± 0.021+ (8) 0.162 ± 0.012 (5)
N^~y 0.087 ± 0.083 (3) -0.1+06 ± 0.030 (6)
/
EE
N^y -0.11+1+ ± 0.05U (1+) -O.369 ± 0.01+0 (5)
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series of antagonists, but the results in the second part
of the table do not justify this# It would seem, therefor 5
that the method might work provided that the change in¬
volved only replacement of methyl groups by ethyl. Much
more information about the effects of more complicated cha¬
nge is needed before it would be possible to know whether
the method of using the antagonists to give estimates of
the changes in the affinity of agonists can be applied
to them. Fortunately, however the more complicated
changes frequently lead to the production of partial
agonists and antagonists in the simpler seiiesj for
example n-pentyl-methylpiperidinium, - ethylpiperidinium
and ethylpyrrolidinium are all pure antagonists of
acetylcholine on the guinea-pig ileum. Consequently the
affinity can be measured directly and there is no need to
use series of antagonists to make assumptions about the
changes in affinity in these series.
the, york, w agagxlafigLa w.Uh the i'rgft rectus
It was decided that the results warranted similar
investigation of compounds on the frog z^ectus preparation,
provided that the results were interpreted with caution.
The variance of the estimates of the log. affinity
constants of the compounds on the frog rectus is rather
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higher than in the experiments on the guinea-pig ileum,
nevertheless the estimates appear to be reasonably
reproducible: the variance is only slightly higher than
that of the estimates of pA« on the guinea-pig ileum by
Sehild (1947)« The variance of the estimates of log.
eyuipotent molar ratios is much smaller than the variance
of log K for the pure antagonists. Each estimate of the
log. equipotent molar ratio, however, is based on a
number of comparisons in a single experiment, whereas
each experiment for measuring affinity constants usually
gives only one comparison in a single experiment, because
the log. dose-response line in the absence of the antag¬
onist i3 obtained only once, at the beginning of the
experiment.
The variance of the estimates of the log. affinity
constant of the partial agonists, is greater than for
the pure antagonists. The results (Table IIB) do not
suggest any reason for preferring one or other of the
two methods used. The first involves the calculation of
the proportion of receptors, £, occupied by a partial
agonist when present in a concentration, P, and the
affinity constant is calculated from equation ( )
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Consequently any error in the measurement of & affects
both the numerator and denominator in opposite directions
and will lead to large differences in the estimate of K^.
One source of variation with the second method ("reciproc
al plot method") is the need for extrapolation in order
to obtain K^. The mean values of the estimates obtained
by the two methods are not significantly different except
with ethylpyridinium. The values of the log. affinity
constant of this compound are significantly different
at a 5% level of probability, but not at a 1% level.
The variance of the estimates, however, is appreciably
lower than that of the other compounds and the difference
would not be significant at a 5% level if the variance
were the same as for methylpyridinium, methyltriethyl-
ammonium or ethylquinuclidinium. It seems likely that
the difference arises from a sampling error and does not
indicate any real difference between the values obtained
by the two methods.
sm am
The results for the simple onium salts (Table IIA)
confirm ana extend the findings of Raventos (1937) that
replacement of methyl groups in tetramethylammonium by
other groups leads to a decline in activity. Figures
and':2b indicate two general tendencies, a decrease in
FIGURE 2a.
Graph of ionic weight against log. equipotent molar
ratio of the agonists relative to tetramethylammoniumj
note that the scale has "been inverted so that the most
active compounds appear at the top of the picture. The
vertical bars indicate the standard deviation: the lines
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FIGURE 2b.
Graph of ionic weight against log. K of the antagonists:
the vertical "bars indicate the standard deviation and
the inner marks indicate the standard error. The lines
join compounds in the same series. EtQ » ethyl-
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FIGU3E 3a.
log conductance
Graph of ratio against log* equipotent molar
ratio of the agonists relative to tetramethylammonium:
note that the scale has been inverted so that the most
active compounds appear at the top of the picture.
The vertical bars indicate the standard deviation and
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Graph of ratio against log. K of the antagonists.
The vertical "bars indicate the standard deviation and
the lines join compounds in the same series.
Pyr = pyridinium, Pyrr = pyrrolidinium, Pip = piperid-


















conductance ratio = A Me^N
A cpd
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potency with increased ionic weight, and an increase in
affinity. If one looks at all the compounds the effects
are not very great, hut within groups, where the increase
in ionic weight is due to replacement of a methyl group
by an ethyl group, the effects are quite clear. In all
three instances in which a methyl group is replaced by
ethyl in the agonists, and in two instances out of three
in the antagonists, the activity is decreased by a
factor of about 3« Where the increase in ionic weight is
brought about by inserting a methylene group to expand
a ring from pyrrolidinlum to piperidinium, the effects
are again in the same direction, but the fall in potency
from dimethylpyrrolidinium to dimethylpiperidinium is
greater than the rise in affinity from diethylpyrrolid¬
inium to die thylpiperidinium.
fhe two trends shown in figures 2a and 2b make it
clear that an increase in ionic weight leads to a
reduction in efficacy and this is particularly clear
when the reduction is such that the compounds become
partial agonists or antagonists, though this may not be
immediately apparent from Figures 2a and 2b because the
compounds now appear on separate graphs. For example,
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dimethyldiethylammonium appears in Figure 2a whereas
methyltriethylammonium, being a partial agonist, appears
in Figure 2b, as does tetraethylammonium, which is a
pure antagonist.
If it is possible to extrapolate the observed change
in affinity per methylene group from the antagonists and
partial agonists in a series to the agonists, it follows
that the general decrease in activity by a factor of 3
per methylene group (Figure 2a), and increase in affinity
by a factor of aoout 3 (Figure 2b), indicate a decrease
in efficacy by a factor of about 9 per methylene group.
In general, the change from agonist to partial
agonists takes place in the range of ionic weights from
110 to 120, and from partial agonist to antagonist in
the range 120 to 130. Methylctuinuclldiniura, however,
with an ionic weight of 126, is still a true agonist,
and likewise ethylcjuinuclidinium is still a partial
agonist, although it has an ionic weight of 16-0. Methyl-
pyridinium, on the other hand, with an ionic weight of
only Skt has such a low efficacy that it is only a partial
agonist. Clearly ionic weight is not the sole influence.
Quinuclidinlum compounds appear to have a lower affinity
and more potency and efficacy than would be expected,
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whereas methylpyridiniumhas more affinity and less
efficacy than would be expected. The quinuclidine ring
system, however, is very compact, and it may be that the
size of the ion is more important than the ionic weight.
The shape of the ion, too, is likely to affect its
properties and it is notable that the ions with flat
rings, methylpyridinium and the pyrrolidinium compounds,
appear to have higher affinities than would be expected.
In contrast ethylquinuclidinium, which has a lower
affinity than might be expected, cannot assume a flat
conformation.
Ion size from conductance measurements
An attempt was made to use the conductance measure¬
ments to assess the size of these ions. A survey of
the compounds had been made by R» Hissett, and originally
it had been hoped to use the values at infinite dilution
to calculate relative ionic radii, using Stokes equation,
r = —ZEi-
6ttn i-]o Ao
Unfortunately, Hissett's values were not consistent
enough for him to calculate Ao. In the attempts to
repeat the work (Table X ), it was apparent that only
the values with high concentrations, (lO^M) gave results
?f-64P.A
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which were consistent , and even these were not exactly
reproducible by different people at different times.
It seems that the apparatus, and in particular the
thermostat, was not adequate for accurate measurements to
be made. Although the resuits are not satisfactory, it
seemed worthwhile trying to use them to see if there
were any obvious correlation between ion size and biolog¬
ical properties. Accordingly the log. equipotent molar
ratios and log. affinity constants have been plotted
against the log. of the conductance ratio, calculated
from the values obtained with lCf^M solutions (Figures
3a ana 3b). This conductance ratio is not a good
measure of ionic radius because the viscosities of the
compounds in 10~aM solutions will not be the same,
nevertheless the ratio could be expected to give some
indication of relative size. A comparison of Figures 2a
and 2b with Figures 3a and 3b indicates that ion size
probably accounts for some of the differences between
the compounds, in particular for the properties of the
quinuclidinium canpounds, and justifies further work on
the ionic conductances. The results obtained with
these simple onium salts suggest that increases in
affinity may be as&ociated with decreases in efficacy.
—68-
The only exceptions appear to "be the pyrrolidiniura
compounds which have relatively high affinity and high
activity. Stephenson (1956) had suggested that, in
general, high affinity for acetylcholine receptors in the
guinea pig ileum was not compatible with high efficacy,
and an incompatibility between high affinity and high
efficacy is readily explained by the "rate theory",
(Paton, 1961). The effect of an extra methylene group,
discussed above, would be to reduce the rate of combin¬
ation of drug with receptor, k^ , by a factor of three
and to reduce the rate of dissociation, k2, by a factor
of nine. This would account for the increase in affinity
K ( = Kj/kg ) ^ a factor of three, and the decrease in
efficacy by a factor of nine.
Analogues of Nicotine
The effects of replacing methyl groups by ethyl in
^-pyridylmetliyltrimethylammonium are very similar to the
effects of replacement in tetramethylammonium itself.
The methyldiethyl compound is a partial agonist and the
triethyl compound purely antagonist, and the affinity
apparently rises with increasing ethylation, although
the difference between the affinities of the methyl¬
diethyl and triethyl compounds is not significant.
-69-
(X. y
Unfortunately the fully ethylated/quaternary
ammonium compounds were not available, hut the affinity
of 0-pyridylmethyldipropylammonium was found to he the
same as that of 0-pyridylmethyltriethylammonium with
which it is isomeric. The results show particularly
clearly the increase in affinity with increasing size of
the suhstituents in the onium group. The effect of
lengthening the chain between the pyridine ring and the
onium group is variable| in three instances there is
an increase, but in two instances there is a decrease
in affinity. In general the 0-compounds have a lower a
affinity than their <* or ^isomers. In the three
comparisons which can be made, the ^ compounds always
have a higher affinity than the 0 compounds. In two
instances out of three, the oC compounds have higher
affinity than the 0 compounds, and ihthe third instance,
there is little difference between them. As the 0
> -
compounds with trimethylammonium or dimethylammonium
groups have the highest activity (Barlow and Hamilton
1963)» it seems likely that, as with the simple onium
salts, the factors which favour binding decrease efficacy.
TABLE XI
oz MW& ma miisma QH Mwm m> Aamirc
ON ERQO RECTUS PREPARATION
Values for agonists are equipotent raolar ratios and are doubly
underlined: all other figures are log, affinity constants, those






92.U + 8.U (6)
3.722 + 0,108 (4)
CH3CHa- 2.867 + 0.07U (4)
VCH2- 3.681 + 0.097 (6)
U.033 ± O.Oke (7)
i+,325 + 0.035 (5)
NOa
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A comparison of the ethyl, pyridyi, and benzyl
compounds (Table XI) indicates the effect of the pyridine
ring on affinity and efficacy. The pyridyi compounds
have about ten times the affinity of the ethyl compound,
and half the affinity of the benzyl compound. The
pyridyi compound has 100 times the activity of both of
these, indicating its importance for efficacy. The ja-
nitro group in the benzene ring apparently increases
affinity about 2-fold, and lowers the efficacy so that
the trimethylammonium compound is a partial agonist:
one slightly puzzling finding is that benzyltriethyl-
ammonium is still a partial agonist. A systematic
survey of the effects of substituents on affinity and
efficacy is at present being made by Mr. G. Thompson.
The tests with the phenylalkyl trialkylammonium
salts were designed to investigate the effects of chain
length on affinity and efficacy, and are not very easy
to understand. The affinity of the compounds does not
rise in a regular way, but again the most active agonist
appears to be likely to have the lowest affinity. The
conductance experiments (Table X ) appear to indicate
that the shapes of the ions may not be altering in a
-71-
regular way, but results of experiments on the guinea-
pig ileum, in the presence of hexamethonium, are more
regular and indicate a gradual rise in affinity. It
seems unlikely, therefore, that the irregular changes
in affinity on the frog rectus can be associated with
irregular changes in ion size because of conformational
irregularities.
Conclusion
The overall impression left by the results with
both the simple onium salts and the analogues of nicotine
is that, in general, high affinity does not lead to high
efficacy, and changes in structure which favour binding
may not, in fact, favour activity.
It is not clear whether this is a generalization or
an absolute rule: it may be that in certain molecules,
the groups produce high efficacy as well as high affinity
but it is quite clear that the interpretation of struct¬
ure-activity relationships simply in terms of "fit" to
receptors is unjustifiable.
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